ARS Pharmaceuticals, Inc. (SPRY)
(Real Time Quote from BATS)
$11.12 USD
-0.22 (-1.94%)
Updated Jul 17, 2024 11:36 AM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/8/24 |
---|---|
Current Quarter | -0.13 |
EPS Last Quarter | -0.11 |
Last EPS Surprise | 0.00% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.65 |
Next Year | -0.63 |
EPS (TTM) | -0.52 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.00M | 2.00M | 6.34M | 59.70M |
# of Estimates | 1 | 1 | 2 | 2 |
High Estimate | 2.00M | 2.00M | 8.00M | 64.00M |
Low Estimate | 2.00M | 2.00M | 4.68M | 55.40M |
Year ago Sales | 0.01M | 0.00M | 0.03M | 6.34M |
Year over Year Growth Est. | 19,900.00% | NA | 21,040.38% | 841.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.13 | -0.19 | -0.65 | -0.63 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.16 | -0.16 | -0.61 | -0.60 |
High Estimate | -0.09 | -0.16 | -0.61 | -0.60 |
Low Estimate | -0.16 | -0.21 | -0.69 | -0.65 |
Year ago EPS | -0.18 | -0.16 | -0.57 | -0.65 |
Year over Year Growth Est. | 27.78% | -18.75% | -14.04% | 3.85% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.13 | -0.19 | -0.65 | -0.63 |
7 Days Ago | -0.13 | -0.19 | -0.65 | -0.63 |
30 Days Ago | -0.13 | -0.19 | -0.65 | -0.63 |
60 Days Ago | -0.13 | -0.19 | -0.72 | -0.41 |
90 Days Ago | -0.13 | -0.17 | -0.69 | -0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.13 | -0.19 | -0.65 | -0.63 |
Zacks Consensus Estimate | -0.13 | -0.19 | -0.65 | -0.63 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.11 | -0.07 | -0.16 | -0.18 | NA |
Estimate | -0.11 | -0.14 | -0.18 | -0.17 | NA |
Difference | 0.00 | 0.07 | 0.02 | -0.01 | 0.02 |
Surprise | 0.00% | 50.00% | 11.11% | -5.88% | 13.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more